NFS Leasing Inc., a Beverly, MA, equipment finance company, has partnered with Gravity Diagnostics, a state-of-the-art CLIA laboratory providing innovative laboratory services including testing of COVID-19. NFS Leasing has financed a total of $2.2 million to date for Gravity Diagnostics.

As the outbreak of COVID-19 has rapidly spread across the world and into the United States, so has the discussion on COVID-19 testing availability, including materials and equipment to support that testing.
 
“Different people and businesses have different roles to play in a crisis such as COVID-19. For Gravity, that role is to assist in ensuring that Americans have rapid testing and results, as ordered by a licensed clinician,” said Tony Remington, CEO of Gravity Diagnostics. “In the past, we have partnered with NFS Leasing to help fuel our growth. This time, we specifically needed NFS to quickly help finance Thermo Fisher systems that enable testing for COVID-19. Once again, NFS helped us find a finance solution fast.”

“These are obviously unprecedented times for many businesses and when we heard Gravity’s story and its urgent need for equipment finance to meet testing demands, we took immediate action to get it done quickly,” stated David DePamphilis, Executive Vice President Sales at NFS Leasing. “As a story lender, we listen to customers that are in unique situations and in need of critical equipment finance, every day. Supporting Gravity in this particular situation is something the NFS Team is extremely proud of. We hope that this equipment will help facilitate the additional and much needed testing of potential COVID-19 patients.”
 
NFS Leasing is a privately held North American leader in equipment finance with more than 18 years of experience. NFS provides solutions supporting businesses and organizations with challenged credit including early stage, start-up and pre-revenue, financially distressed companies and turn-arounds. NFS uses its own balance sheet capital and provides fast flexible credit decisions.